NEW YORK, March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or the "Company") (NYSE: CE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Cleanese and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, March 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or the "Company") (NYSE: CE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Cleanese and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

DALLAS, March 5, 2025 /PRNewswire/ -- Celanese Corporation (NYSE: CE) ("Celanese"), a global chemical and specialty materials company, today announced that its direct wholly-owned subsidiary Celanese US Holdings LLC (the "Company") has commenced offers to purchase for cash any validly tendered (and not validly withdrawn) and accepted notes in an aggregate principal amount of up to (i) €500,000,000 of 4.777% Senior Notes due 2026 (the "EUR Notes") and (ii) $250,000,000 of 6.415% Senior Notes due 2027 (the "USD Notes," and together with the EUR Notes, the "Notes") (which, in each case subject to applicable law, may be increased or decreased in the sole discretion of the Company (such amount for the applicable series of Notes, as the same may be increased or decreased, the "Series Cap")) as described in the table below (the "Tender Offers").

NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Celanese Corporation ("Celanese" or the "Company") (NYSE: CE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Cleanese and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Feb. 18, 2025 /PRNewswire/ -- 

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Celanese Corporation (NYSE: CE) resulting from allegations that Celanese may have issued materially misleading business information to the investing public.

So What: If you purchased Celanese securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

NEW YORK, Feb. 12, 2025 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Celanese Corporation (NYSE: CE) resulting from allegations that Celanese may have issued materially misleading business information to the investing public.

So What: If you purchased Celanese securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

NEW YORK, Feb. 6, 2025 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Celanese Corporation (NYSE: CE) resulting from allegations that Celanese may have issued materially misleading business information to the investing public.

So What: If you purchased Celanese securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

NEW YORK, Jan. 31, 2025 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Celanese Corporation (NYSE: CE) resulting from allegations that Celanese may have issued materially misleading business information to the investing public.

So What: If you purchased Celanese securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

NEW YORK, Jan. 27, 2025 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Celanese Corporation (NYSE: CE) resulting from allegations that Celanese may have issued materially misleading business information to the investing public.

So What: If you purchased Celanese securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

NEW YORK, Jan. 20, 2025 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Celanese Corporation (NYSE: CE) resulting from allegations that Celanese may have issued materially misleading business information to the investing public.

So What: If you purchased Celanese securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.